Literature DB >> 28901492

Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review).

Qing Zhang1, Shu Ding2, Huilin Zhang3.   

Abstract

Hematopoietic progenitor kinase 1 (HPK1), also known as mitogen‑activated protein kinase kinase kinase kinase 1 is a serine/threonine protein kinase. It is involved in various cellular events, including mitogen‑activated protein kinase signaling, nuclear factor‑κB signaling, cytokine signaling, cellular proliferation and apoptosis, T cell receptor/B cell receptor signaling and T/B/dendritic cell‑mediated immune responses. Therefore, HPK1 has variety of roles in immunity, and is associated with the pathogenesis of autoimmune diseases, cancer, and the inflammatory response. In these cellular and immune events, HPK1 interacts with several adaptor proteins, including caspase recruitment domain family, member 11, hematopoietic cell‑specific protein 1, HPK1‑interacting protein of 55 kDa, the growth factor receptor‑bound protein 2 family, linker for activated T‑cells, the SH2 domain‑containing leukocyte protein of 76 kDa family, the v‑crk avian sarcoma virus CT10 oncogene homolog family, B‑cell adaptor molecule of 32 kDa and non‑catalytic region of tyrosine kinase adaptor protein. These adaptor proteins can couple HPK1 with various effector molecules, leading to the transmission of upstream signals to downstream targets. They are crucial in regulating the relocation, phosphorylation, activation and functions of HPK1. HPK1 can also phosphorylate certain proteins, consequently modulating their functions. This review aims to describe the adaptor proteins, which interact with HPK1, particularly focusing on their modes of interaction with HPK1, and the effects that these interactions cause.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28901492     DOI: 10.3892/mmr.2017.7494

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses.

Authors:  Michael Agrez; Justyna Rzepecka; Darryl Turner; Gavin Knox; Christopher Chandler; Christopher B Howard; Nicholas Fletcher; Kristofer Thurecht; Stephen Parker; Hayley Gooding; Laura Gallagher
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

2.  Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function.

Authors:  Yun Wang; Kelvin Zhang; Peter Georgiev; Steven Wells; Haiyan Xu; Brian M Lacey; Zangwei Xu; Jason Laskey; Robbie Mcleod; Joey L Methot; Mark Bittinger; Alexander Pasternak; Sheila Ranganath
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

Review 3.  A perspective on HPK1 as a novel immuno-oncology drug target.

Authors:  Sansana Sawasdikosol; Steven Burakoff
Journal:  Elife       Date:  2020-09-08       Impact factor: 8.140

4.  Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia.

Authors:  Zhenjie Bai; Qingmei Yao; Zhongyi Sun; Fang Xu; Jicheng Zhou
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

Review 5.  CG-NAP/Kinase Interactions Fine-Tune T Cell Functions.

Authors:  Navin Kumar Verma; Madhavi Latha Somaraju Chalasani; John D Scott; Dermot Kelleher
Journal:  Front Immunol       Date:  2019-11-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.